ArticleCase reports in ophthalmological medicine2015
Managing Drawbacks in Unconventional Successful Glaucoma Surgery: A Case Report of Stent Exposure.
Article in Case reports in ophthalmological medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- PreserFlo MicroShunt® exposure: a case series.BMC ophthalmology · 2021Article
- Postoperative complications of Ab-Interno XEN implantation in primary angle closure glaucoma.American journal of clinical and experimental immunology · 2021Article
- XEN Gel Stent in the management of primary open-angle glaucoma.Documenta ophthalmologica. Advances in ophthalmology · 2020Article
- XENClinical ophthalmology (Auckland, N.Z.) · 2020Review
- [MIGS-off-label option for treatment-refractory steroid-induced ocular hypertension].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020Article
- A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration.BMC biomedical engineering · 2020Article
- Amniotic Membrane Transplantation in Ophthalmology: An Updated Perspective.Clinical ophthalmology (Auckland, N.Z.) · 2020Review
- SUBCONJUNCTIVAL FRAGMENTATION OF A PREVIOUSLY EFFICIENT XEN GEL STENT IMPLANTATION AND SUCCESSFUL BLEB FORMATION: A CASE REPORT.Acta clinica Croatica · 2019Article
- Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study.Clinical & experimental ophthalmology · 2019Article
- Dislocation of a previously successful XEN glaucoma implant into the anterior chamber: a case report.BMC ophthalmology · 2017Article
- XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications.Journal of ophthalmology · 2017Article
- Safety and Efficacy of Microinvasive Glaucoma Surgery.Journal of ophthalmology · 2017Review
- Outcomes of XEN Gel Stent Implantation in the Inferonasal Quadrant after Failed Trabeculectomy.Journal of current glaucoma practiceArticle
- Superonasal vs Inferonasal Subconjunctival Gel Stent Placement in Patients with Glaucoma.Journal of current glaucoma practiceArticle
- How to Rescue of the Dislocated XENJournal of current ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional options in managing failed trabeculectomy (bleb needling, revision, additional incisional surgery and tube surgery) have a relatively high failure and complication rate. The use of microinvasive glaucoma surgery (MIGS) has generally been reserved to mild to moderate glaucoma cases, proving good safety profiles but significant limitations in terms of efficacy. We describe a patient who underwent MIGS (XEN Aquesys subconjunctival shunt implantation) after a prior failed trabeculectomy. After the surgery, the IOP was well controlled but as the stent was close to an area of scarred conjunctiva of the previous trabeculectomy, it became partially exposed. As a complete success was achieved, we decided to remove the conjunctiva over the exposed area and replace it by an amniotic membrane transplantation and a conjunctiva autograft. Six months after surgery, the unmedicated IOP is still well controlled with complete visual acuity recovery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.